Pruritus, Atopic Dermatitis Clinical Trial
Official title:
A Phase II, Randomised, Double-blind, Vehicle-controlled, Cross-over Study to Determine the Anti-pruritic Efficacy, Safety and Local Dermal Toleration of SRD174 Cream in Subjects With Atopic Dermatitis.
Pruritus is an essential feature for the diagnosis of atopic dermatitis and may play an
important part in disease progression. Itching has a significant impact on the quality of
life of AD sufferers, in particular night-time itching leading to sleep disturbance and
subsequent poor daytime performance.
The objective of this study is to determine whether SRD174 Cream is a safe and effective
therapy for moderate to severe pruritus associated with atopic dermatitis.
n/a
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment